Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Descovy
Pharma
GSK bolsters case for long-acting HIV PrEP drug Apretude
With GSK girding for competition from Gilead, the company has presented strong results from three real-world studies of HIV prevention drug Apretude.
Kevin Dunleavy
Oct 16, 2024 1:26pm
Gilead aims to shake up HIV PrEP market with long-acting launch
Aug 9, 2024 11:42am
US appeals Gilead's trial win in Truvada, Descovy patent fight
Jul 9, 2024 11:00am
Gilead locks in with dancer for HIV awareness voguing workshop
Apr 3, 2024 7:35am
Gilead bests US government in HIV PrEP patent case
May 9, 2023 4:45pm
Gilead, US set to clash at trial over PrEP drug patents
May 2, 2023 9:35am
